<DOC>
	<DOC>NCT00168870</DOC>
	<brief_summary>This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.</brief_summary>
	<brief_title>Study of Metastatic Ocular Melanoma</brief_title>
	<detailed_description>Treatment of patients with metastatic ocular melanoma with combination chemotherapy Gemcitabine and Treosulfan versus monotherapy with Treosulfan as first-line chemotherapy.</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Treosulfan</mesh_term>
	<criteria>Metastatic ocular melanoma Prior treatment with chemotherapy Active 2nd malignancy Cerebral metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>metastatic ocular melanoma</keyword>
</DOC>